Increased bone pain after suspension of buserelin treatment in disseminated prostatic cancer.
D001859:Bone Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D002064:Buserelin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000503:physiopathology*; D011471:Prostatic Neoplasms
D002064:Buserelin